Abstract
Current research employed electrical records from superior vagus and sympathetic nerve branch that supply fat retroperitoneal tissue (RS nerve) to investigate whether very moderate swim training in obese-programmed mice would change sympathetic and parasympathetic autonomic nervous system activities. Neonatal mice were treated with monosodium l-glutamate (MSG), during their first 5 days of life, to induce obesity. Mice started training on weaning, comprising free swimming 3 days/week, 15 min/day for 10 weeks. After 12 h fasting, the nerve electrical signals of the 90-day-old mice were processed to obtain firing rates. Blood samples were collected to measure glucose and insulin levels. Adrenal catecholamine content was measured. MSG treatment caused obesity. Hyperglycemia and hyperinsulinemia in MSG-obese mice, without any change in food intake, were obtained. Vagus firing rates were higher in obese mice than those in lean ones. A decrease in RS nerve activity and lower adrenal catecholamine stores have been observed. Swimming normalized blood glucose and insulin levels and MSG-obesity onset was attenuated by exercise. Vagus activity from obese mice decreased, whereas RS nerve activity and adrenal catecholamine levels increased in trained ones. Results suggest that autonomic activity imbalance and metabolic dysfunctions observed in MSG-obese mice were inhibited by precocious and moderate exercise training.
Similar content being viewed by others
References
F. Bacha, R. Saad, N. Gungor, S.A. Arslanian, Diabetes Care 29(7), 1599–1604 (2006)
G.A. Bray, T. Bellanger, Endocrine 29(1), 109–117 (2006)
S.M. Phillips et al., Obes. Res. 12(3), 461–472 (2004)
R.A. Winett, D.F. Tate, E.S. Anderson, J.R. Wojcik, S.G. Winett, Prev. Med. 41(2), 629–641 (2005)
S.C. Woods, M.W. Schwartz, D.G. Baskin, R.J. Seeley, Annu. Rev. Psychol. 51, 255–277 (2000)
T. Adage et al., J. Neurosci. 21(10), 3639–3645 (2001)
T. Kishi, J. Horiguchi, Nihon Shinkei Seishin Yakurigaku Zasshi 23(5), 197–203 (2003)
G.A. Tejwani, C.W. Richard III, NIDA Res. Monogr. 75, 497–500 (1986)
J.W. Olney, Science 164, 719–721 (1969)
G.A. Bray, Int. J. Obes. 11(Suppl 3), 83–95 (1987)
L. Freire-Maia, A.D. Azevedo, Med. Hypotheses 32(2), 91–99 (1990)
N. Atef, A. Ktorza, L. Picon, L. Penicaud, Am. J. Physiol. 262(5 Pt 1), E736–E740 (1992)
F.S. Leigh, L.N. Kaufman, J.B. Young, Int. J. Obes. Relat. Metab. Disord. 16(8), 597–604 (1992)
S. Inoue, G.A. Bray, Life Sci. 25(7), 561–566 (1979)
R.J. Barnard, S.J. Wen, Sports Med. 18(4), 218–228 (1994)
D.S. Hittel, W.E. Kraus, C.J. Tanner, J.A. Houmard, E.P. Hoffman, J. Appl. Physiol. 98(1), 168–179 (2005)
T. Hayashi, J.F. Wojtaszewski, L.J. Goodyear, Am. J. Physiol. 273(6 Pt 1), E1039–E1051 (1997)
J.J. Betts, W.M. Sherman, M.J. Reed, J.P. Gao, Obes. Res. 1(4), 295–302 (1993)
H. Zouhal et al., Int. J. Sports Med. 19(3), 172–176 (1998)
A.J. Scheurink et al., Am. J. Physiol. 256(1 Pt 2), R161–R168 (1989)
A.J. Scheurink et al., Am. J. Physiol. 256(1 Pt 2), R155–R160 (1989)
B. Stallknecht, M. Roesdahl, J. Vinten, K. Capito, H. Galbo, Acta Physiol. Scand. 156(4), 465–473 (1996)
T.J. Bartness, C.K. Song, Lipid Res. 48(8), 1655–1672 (2007)
B. Stallknecht et al., Am. J. Physiol. 259(5 Pt 2), R998–R1003 (1990)
S. Lucinei Balbo, C. Gravena, M.L. Bonfleur, P.C. de Freitas Mathias, Horm. Res. 54(4), 186–191 (2000)
D.X. Scomparin et al., Life Sci. 79(22), 2151–2156 (2006)
K. Hamaoka, T. Kusunoki, J. Nutr. Sci. Vitaminol. (Tokyo) 32(4), 395–411 (1986)
F. Rohner-Jeanrenaud et al., J. Physiol. (Paris) 78(9), 833–837 (1982)
R.A. Batt, C.A. Wilson, D.L. Topping, Int. J. Obes. 2(3), 303–307 (1978)
M.Y. Loh, W.P. Flatt, R.J. Martin, D.B. Hausman, Proc. Soc. Exp. Biol. Med. 218(1), 38–44 (1998)
D.P. Cameron, L. Cutbush, F. Opat, Clin. Exp. Pharmacol. Physiol. 5(1), 41–51 (1978)
D.P. Cameron, T.K. Poon, G.C. Smith, Diabetologia 12(6), 621–626 (1976)
P. de Carvalho Papa, A.M. Vargas, J.L. da Silva, M.T. Nunes, U.F. Machado, Life Sci. 71(16), 1917–1928 (2002)
U.F. Machado, I. Shimizu, M. Saito, Physiol. Behav. 55(4), 621–625 (1994)
H. Inoue, S. Kohsaka, M. Otani, S. Toya, Y. Tsukada, Neurosci. Res. 3(6), 555–567 (1986)
S.L. Balbo et al., Res. Commun. Mol. Pathol. Pharmacol. 108(5–6), 291–296 (2000)
S.L. Balbo et al., Diabetes Metab. 28(6 Pt 2), 3S13–3S17 (2002). discussion 13S108-112
S.L. Balbo et al., Endocrine 31(2), 142–148 (2007)
T. Kiba, K. Tanaka, O. Endo, S. Inoue, Gastroenterology 104(2), 475–484 (1993)
A.V. Astrup, N.J. Christensen, L. Simonsen, J. Bulow, J. Neurosci. Methods 34(1–3), 187–192 (1990)
A.R. Carpinelli, U.F. Machado, R. Curi, Neurosci. Biobehav. Rev. 20(2), 183–188 (1996)
R. Dawson Jr., Z. Annau, Brain Res. Bull. 15(2), 117–121 (1985)
C.M. Patterson, B.E. Levin, Neuroendocrinology 87(2), 65–70 (2008)
C. Napoli et al., Proc. Natl Acad. Sci. USA 101(23), 8797–8802 (2004)
J.M. Jakicic, J. Nutr. 132(12), 3826S–3829S (2002)
J.M. Jakicic, A.D. Otto, Am. J. Clin. Nutr. 82(1 Suppl), 226S–229S (2005)
H.O. Chambliss, Clin. J. Sport Med. 15(2), 113–115 (2005)
C.M. Patterson, A.A. Dunn-Meynell, B.E. Levin, Am. J. Physiol. Regul. Integr. Comp. Physiol. 294(2), R290–R301 (2008)
C.D. West, T.L. Kemper, Brain Res. 107(2), 221–237 (1976)
V.V. Prasad, Lipids 26(7), 553–556 (1991)
A. Plagemann et al., Int. J. Dev. Neurosci. 17(1), 37–44 (1999)
H. Davidowa, Y. Li, A. Plagemann, Zh. Vyssh. Nerv. Deiat. Im. I. P. Pavlova 53(5), 663–670 (2003)
H. Yoshimatsu, Y. Oomura, T. Katafuchi, A. Niijima, Am. J. Physiol. 253(3 Pt 2), R418–R424 (1987)
G.A. Bray, S. Inoue, Y. Nishizawa, Diabetologia 20(Suppl), 366–377 (1981)
G.A. Bray, Int. J. Obes. 8(Suppl 1), 119–137 (1984)
S. Inoue, G.A. Bray, Endocrinology 100(1), 108–114 (1977)
T.J. Bartness, J. Clin. Invest. 110(9), 1235–1237 (2002)
P.C. Mathias, L. Best, W.J. Malaisse, Cell Biochem. Funct. 3(3), 173–177 (1985)
S. Grassiolli, C. Gravena, P.C. de Freitas Mathias, Eur. J. Pharmacol. 556(1–3), 223–228 (2007)
J.A. Romijn, E. Fliers, Curr. Opin. Clin. Nutr. Metab. Care 8(4), 440–444 (2005)
A. Giordano et al., Am. J. Physiol. Regul. Integr. Comp. Physiol. 291(5), R1243–R1255 (2006)
B. Balkan, G. Van Dijk, J.H. Strubbe, J.E. Bruggink, A.B. Steffens, Am. J. Physiol. 262(6 Pt 2), R981–R985 (1992)
A.C. Martins et al., Life Sci. 74(26), 3211–3222 (2004)
N. Uysal et al., Neurosci. Lett. 383(3), 241–245 (2005)
S.A. Neeper, F. Gomez-Pinilla, J. Choi, C.W. Cotman, Brain Res. 726(1–2), 49–56 (1996)
A.S. Moura, A.R. Carpinelli, F.B. Barbosa, C. Gravena, P.C. Mathias, Res. Commun. Mol. Pathol. Pharmacol. 92(1), 73–84 (1996)
L.L. Bernardis, B.D. Patterson, J. Endocrinol. 40(4), 527–528 (1968)
R.M. Torrezan RG, M.L. Ferrarese, F.B. de Melo, A.M.D. Ramos, P.C.F. Mathias, D.X. Scomparin, Arq. Bras. Endocrinol. Metabol. 52(9), 1489–1496 (2008)
V. Leclercq-Meyer, J. Marchand, O. Rebolledo, W.J. Malaisse, R. Leclercq, Diabetologia 11(5), 419–425 (1975)
A.C.P. Martins, H.E. Borges, R.M.G. Garcia, S.R. Carniatto, P.C.F. Mathias, Neurosci. Res. Commun. 28(1), 49–57 (2001)
K.L. Kelner, R.A. Levine, K. Morita, H.B. Pollard, Neurochem. Int. 7, 373–378 (1985)
Acknowledgments
Current research was funded by the Brazilian Research Agencies: CNPq, CAPES, and Fundação Araucaria.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scomparin, D.X., Gomes, R.M., Grassiolli, S. et al. Autonomic activity and glycemic homeostasis are maintained by precocious and low intensity training exercises in MSG-programmed obese mice. Endocr 36, 510–517 (2009). https://doi.org/10.1007/s12020-009-9263-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-009-9263-2